Highlights INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Delayed Nasdaq Other stock markets 03:28:02 2024-05-21 pm EDT			5-day change	1st Jan Change
0.9142 ^USD	-1.59%		-18.38%	-32.28%

Apr. 18	Top Premarket Decliners	MT
Apr. 17	Sector Update: Health Care Stocks Retreating Late Afternoon	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Premarket Decliners	Apr. 18	MT
Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
Top Midday Gainers	Apr. 17	MT
Traders Digest Earnings After Rate-Driven Losses, US Equity Futures Rebound Slightly	Apr. 17	MT
Top Premarket Gainers	Apr. 17	MT
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 16	CI
NAYA Biosciences Inc. Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal	Dec. 11	CI
Earnings Flash (INVO) INVO BIOSCIENCE Reports Q3 Revenue $974,894	Nov. 13	MT
INVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
INVO Bioscience Shares Skyrocket After Signing Deal to Buy NAYA Biosciences	23-10-23	MT
NAYA Biosciences entered into an agreement to acquire INVO Bioscience, Inc. in a reverse merger transaction for $90.7 million.	23-10-22	CI
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q2 Revenue $315,902, vs. Street Est of $450,000	23-08-14	MT
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
INVO Bioscience Closes Wisconsin Fertility Institute Acquisition	23-08-11	MT
INVO Bioscience, Inc. Receives 510(K) FDA Clearance for Expanded Use of the Invocell Device	23-06-27	CI
Earnings Flash (INVO) INVO BIOSCIENCE Posts Q1 Revenue $348,025, vs. Street Est of $374,000	23-05-15	MT
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
INVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
INVO Bioscience, Inc. Provides Earnings Guidance for the Fourth Quarter and Year Ended December 31, 2022	23-03-30	CI
INVO Bioscience to Acquire Wisconsin Fertility Institute for $10 Million; Shares Jump	23-03-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights INVO Bioscience, Inc.

Equities

INVO

US44984F4019

Highlights

Filters